Patents expiring in 2028

US 7316811

Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles

Nektar Therapeutics AL, Corporation · Granted Tue Jan 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7317023

Diaryl ether β2 adrenergic receptor agonists

Theravance, Inc. · Granted Tue Jan 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7317102

Diarylmethyl and related compounds

Theravance, Inc. · Granted Tue Jan 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7317086

Basal cell carcinoma tumor suppressor protein

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7317127

Process for the optical resolution and recycling of tomoxetine

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Jan 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7317022

Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists

Theravance, Inc. · Granted Tue Jan 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7317020

Isolation and structure of Cribrostatin 6

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA · Granted Tue Jan 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7319091

Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7319015

Methods and compositions for using alveolar macrophage phospholipase A2

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7319134

Regulation of transcription factor, NF-IL6/LAP

The Regents of the University of California · Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7319171

Sertraline hydrochloride form II and methods for the preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7318861

Effect pigment

BASF CATALYSTS LLC · Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7319000

Compositions and methods for eliciting immune or anti-infective responses

The Board of Regents of the University of Texas System · Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7320965

Compositions and methods for inhibiting expression of Huntingtin gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7321063

Sulfonamide inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7321065

Thyronamine derivatives and analogs and methods of use thereof

The Regents of the University of California · Granted Tue Jan 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7320990

Crystalline form of a biphenyl compound

Theravance, Inc. · Granted Tue Jan 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7320783

Methods and compositions for the enhancement of wound healing

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7320991

Analogs of thalidomide as potential angiogenesis inhibitors

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Jan 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7323334

Screening and therapeutic methods relating to neurogenesis

The Regents of the University of California · Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7323171

Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7323340

Compositions and methods for regulating bacterial pathogenesis

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7323459

Crystal forms, methods for their preparation and method for preparation of olanzapine

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7323165

Production of pancreatic islet cells and delivery of insulin

The Regents of the University of California · Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7323616

Genetically altered mice deficient in functional caspase-9

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7323297

Stabilized polynucleotide complexes and methods

The Regents of the University of California · Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7323541

Polypeptide DNA thereof and use of the same

Takeda Pharmaceutical Company Limited · Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7323166

Lactic acid bacteria cultures that inhibit food-borne pathogens

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7323174

Modulation of immune response and methods based thereon

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7323173

Methods for treating breast cancer using a mammary cell growth inhibitor

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7326691

Compositions comprising amphotericin B, methods, and systems

Nektar Therapeutics · Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7326542

Compositions and methods for regulating bacterial pathogenesis

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7326570

Induction of tubular morphogenesis using pleiotrophin

The Regents of the University of California · Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7326790

Diphenylisoxazole compounds and hydro isomers thereof

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7326695

Anti-bacterial agents based upon oxoanion binding

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7326697

Methods for increasing the therapeutic response to electroconvulsive therapy

Corcept Therapeutics Incorporated · Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7326712

Substituted tricyclic compounds as protein kinase inhibitors

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7326713

Substituted tricyclic compound as protein kinase inhibitors

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7326734

Treatment of bladder and urinary tract cancers

The Regents of the University of California · Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329502

ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329511

Nucleic acid encoding GAD65

The Regents of the University of California · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329638

Drug delivery compositions

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329642

β-2-glycoprotein is an inhibitor of angiogenesis

The Board of Regents of the University of Texas System · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329759

Illudin analogs useful as antitumor agents

The Regents of the University of California · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329681

Inhibitors of IMPDH enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329401

Cyclooxygenase-2 selective agents useful as imaging probes and related methods

The Regents of the University of California · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329652

Diaminotriazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329651

Cannabimimetic ligands

UNIVERSITY OF CONNECTICUT · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)